Overview
Ozempic is a brand name for semaglutide, a medication belonging to the GLP-1 receptor agonist class, primarily used for managing type 2 diabetes and chronic weight management. It works by mimicking a natural hormone to regulate blood sugar and slow gastric emptying.
Current status
Ozempic is currently classified as Dormant. Dormant means there has been no significant new coverage recently. Peak interest was on Mar 20, 05:16 PM.
Recent events
Research indicates that GLP-1 drugs affect men and women differently.
Mar 10, 06:22 PM · GLP-1 Medications Impact and Risks
The article explores the reasons behind these observed differences in how the medication impacts each gender.
Ozempic-like drugs may increase the risk of bone and joint conditions.
Mar 10, 12:03 PM · GLP-1 Medications Impact and Risks
ScienceAlert reports on potential side effects associated with this class of medications, including adverse effects on bone and joint health.